Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acarbose versus metformin in newly diagnosed elderly type 2 diabetes
ChiCTR1900021632Phase 4Recruiting
- Sponsor
- Xiangtan First People's Hospital
- Start
- Mar 2019
- Modality
- Small Molecules, Microbiome-Derived Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of acarbose and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Xiangtan First People's Hospital. Primary endpoint: HbA1c. Started Mar 2019; status: recruiting.
02
Drugs
acarbosemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR1900021632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021632.